{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:51:46Z","timestamp":1785405106317,"version":"3.56.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bpobgyn.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T21:07:51Z","timestamp":1558732071000},"page":"24-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Current and potential methods for second trimester abortion"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-9814","authenticated-orcid":false,"given":"Klaira","family":"Lerma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10041","key":"10.1016\/j.bpobgyn.2019.05.006_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(16)30380-4","article-title":"Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends","volume":"388","author":"Sedgh","year":"2016","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.bpobgyn.2019.05.006_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6625a1","article-title":"Abortion Surveillance-United States, 2014. Morbidity and mortality weekly report","volume":"66","author":"Jatlaoui","year":"2018","journal-title":"Surveillance summ"},{"key":"10.1016\/j.bpobgyn.2019.05.006_bib3","series-title":"Abortion statistics","author":"Department of Health","year":"2017"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib4","first-page":"CD006714","article-title":"Surgical versus medical methods for second trimester induced abortion","author":"Lohr","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.contraception.2013.10.015","article-title":"Medical termination of pregnancy during the second versus the first trimester and its effects on subsequent pregnancy","volume":"89","author":"Mannisto","year":"2014","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1067\/mob.2002.123887","article-title":"A\u00a0comparison of medical induction and dilation and evacuation for second-trimester abortion","volume":"187","author":"Autry","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1471-0528.2003.00044.x-i1","article-title":"Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial","volume":"111","author":"Grimes","year":"2004","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.05.006_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ijgo.12229","article-title":"Comparison of complications associated with induction by misoprostol versus dilation and evacuation for second-trimester abortion","volume":"138","author":"Sonalkar","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.AOG.0000130842.21897.53","article-title":"Methods for induced abortion","volume":"104","author":"Stubblefield","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/AOG.0000000000000603","article-title":"Incidence of emergency department visits and complications after abortion","volume":"125","author":"Upadhyay","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib11","first-page":"185","article-title":"Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases","volume":"62","author":"Peterson","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/AOG.0b013e3182a2dcb7","article-title":"Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial","volume":"122","author":"Elami-Suzin","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2011.02.005","article-title":"Clinical guidelines. Labor induction abortion in the second trimester","volume":"84","author":"Borgatta","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.05.006_bib14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.AOG.0000431056.79334.cc","article-title":"ACOG practice bulletin No. 135: second-trimester abortion","volume":"121","author":"The American College of Obstetricians and Gynecologists","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.05.006_bib15","series-title":"Best practice in comprehensive abortion care","author":"Royal College of Obstetricians & Gynaecologists","year":"2015"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2011.07.013","article-title":"The combination of mifepristone and misoprostol for the termination of pregnancy","volume":"115","author":"Fa\u00fandes","year":"2011","journal-title":"Int J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.05.006_bib17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jogc.2017.12.010","article-title":"No. 360-Induced abortion: surgical abortion and second trimester medical methods","volume":"40","author":"Costescu","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.05.006_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/AOG.0b013e318227214e","article-title":"Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial","volume":"118","author":"Ngoc","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.humrep.a135965","article-title":"Pregnancy: induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens","volume":"10","author":"El-Refaey","year":"1995","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1472-6483(10)60522-6","article-title":"One-and 2-day mifepristone\u2013misoprostol intervals are both effective in medical termination of second-trimester pregnancy","volume":"8","author":"Heikinheimo","year":"2004","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib21","first-page":"CD005216","article-title":"Medical methods for mid-trimester termination of pregnancy","author":"Wildschut","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.05.006_bib22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: a randomized controlled trial","volume":"110","author":"Kapp","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/humupd\/dml049","article-title":"Mid-trimester induced abortion: a review","volume":"13","author":"Lalitkumar","year":"2007","journal-title":"Hum Reprod Update"},{"issue":"31 Suppl","key":"10.1016\/j.bpobgyn.2019.05.006_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0968-8080(08)31371-8","article-title":"Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management","volume":"16","author":"Gemzell-Danielsson","year":"2008","journal-title":"Reprod Health Matters"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2015.02.023","article-title":"A\u00a0double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy","volume":"130","author":"Dabash","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"10.1016\/j.bpobgyn.2019.05.006_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161843","article-title":"Clinical outcomes and women's experiences before and after the introduction of mifepristone into second-trimester medical abortion services in South Africa","volume":"11","author":"Constant","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.bpobgyn.2019.05.006_bib27","first-page":"S160","article-title":"Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"issue":"3 Pt 1","key":"10.1016\/j.bpobgyn.2019.05.006_bib29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: drug absorption and uterine response","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00404-012-2508-y","article-title":"Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial","volume":"287","author":"Tanha","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.05.006_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/AOG.0000000000000946","article-title":"Vaginal misoprostol compared with buccal misoprostol for termination of second-trimester pregnancy: a randomized controlled trial","volume":"126","author":"Al","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/13625187.2016.1258461","article-title":"Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia","volume":"22","author":"Louie","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.05.006_bib34","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/AOG.0000000000000290","article-title":"Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial","volume":"123","author":"Dickinson","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jog.12147","article-title":"Randomized controlled trial comparing efficacy between a vaginal misoprostol loading and non-loading dose regimen for second-trimester pregnancy termination","volume":"40","author":"Pongsatha","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.bpobgyn.2019.05.006_bib36","series-title":"Medical management of abortion, 2018","author":"World Health Organization","year":"2018"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.05.006_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/AOG.0b013e3182932f37","article-title":"Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review","volume":"121","author":"Shaw","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.05.006_bib38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AOG.0000000000001688","article-title":"Simultaneous administration compared with a 24-hour mifepristone-misoprostol interval in second-trimester abortion: a randomized controlled trial","volume":"128","author":"Abbas","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.05.006_bib39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.contraception.2018.03.022","article-title":"Investigation of a variable mifepristone to misoprostol interval for second trimester medical abortion","volume":"97","author":"Henkel","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2019.05.006_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2018.12.004","article-title":"Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies","author":"Shochet","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2019.05.006_bib41","doi-asserted-by":"crossref","first-page":"j2011","DOI":"10.1136\/bmj.j2011","article-title":"Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland","volume":"357","author":"Aiken","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.bpobgyn.2019.05.006_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bmjsrh-2018-200102","article-title":"Second-trimester medication abortion outside the clinic setting: an analysis of electronic client records from a safe abortion hotline in Indonesia","volume":"44","author":"Gerdts","year":"2018","journal-title":"BMJ Sex Reprod Health"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.05.006_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.contraception.2007.09.004","article-title":"Cervical preparation for second-trimester surgical abortion prior to 20 weeks of gestation","volume":"76","author":"Fox","year":"2007","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2019.05.006_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.contraception.2008.01.004","article-title":"Clinical guidelines. Cervical preparation for surgical abortion from 20 to 24 weeks' gestation","volume":"77","author":"Newmann","year":"2008","journal-title":"Contraception"},{"issue":"2 Pt 1","key":"10.1016\/j.bpobgyn.2019.05.006_bib45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/AOG.0000000000000080","article-title":"Same-day synthetic osmotic dilators compared with overnight laminaria before abortion at 14-18 weeks of gestation: a randomized controlled trial","volume":"123","author":"Newmann","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.05.006_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.contraception.2016.05.008","article-title":"Synthetic osmotic dilators with adjunctive misoprostol for same-day dilation and evacuation: a randomized controlled trial","volume":"94","author":"Boraas","year":"2016","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ajog.2005.08.016","article-title":"Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial","volume":"194","author":"Edelman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2019.05.006_bib48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.contraception.2005.10.004","article-title":"Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy","volume":"73","author":"Patel","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2019.05.006_bib49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.contraception.2013.10.013","article-title":"Buccal misoprostol plus laminaria for cervical preparation before dilation and evacuation at 21-23 weeks of gestation: a randomized controlled trial","volume":"89","author":"Drey","year":"2014","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.AOG.0000168629.17326.00","article-title":"Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial","volume":"106","author":"Goldberg","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.05.006_bib51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/AOG.0000000000000977","article-title":"Cervical preparation before dilation and evacuation using adjunctive misoprostol or mifepristone compared with overnight osmotic dilators alone: a randomized controlled trial","volume":"126","author":"Goldberg","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.05.006_bib52","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1097\/01.AOG.0000447250.38819.1f","article-title":"Mifepristone and misoprostol compared with osmotic dilator insertion before surgical abortion at 15-18 weeks","volume":"123","author":"Paris","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2019.05.006_bib53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.contraception.2014.11.014","article-title":"Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial","volume":"91","author":"Shaw","year":"2015","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.05.006_bib54","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.contraception.2014.07.008","article-title":"Intrauterine lidocaine for pain control during laminaria insertion: a randomized controlled trial","volume":"90","author":"Mercier","year":"2014","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.05.006_bib55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.contraception.2018.11.013","article-title":"Self-administered lidocaine gel for local anesthesia prior to osmotic dilator placement: a randomized trial","volume":"99","author":"Schivone","year":"2019","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0000000000002149","article-title":"Paracervical block for laminaria insertion before second-trimester abortion: a randomized controlled trial","volume":"130","author":"Soon","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.05.006_bib57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.contraception.2012.05.002","article-title":"Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial","volume":"86","author":"Borgatta","year":"2012","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/AOG.0b013e3182983889","article-title":"Buccal misoprostol compared with synthetic osmotic cervical dilator before surgical abortion: a randomized controlled trial","volume":"122","author":"Bartz","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.05.006_bib59","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2014.05.003","article-title":"A\u00a0randomized trial of misoprostol versus laminaria before dilation and evacuation in South Africa","volume":"90","author":"Grossman","year":"2014","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.bpobgyn.2019.05.006_bib60","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2015.04.005","article-title":"Misoprostol 1 to 3 h preprocedure vs. overnight osmotic dilators prior to early second-trimester surgical abortion","volume":"92","author":"Ramesh","year":"2015","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.05.006_bib61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.contraception.2012.12.010","article-title":"Same-day cervical preparation with misoprostol prior to second trimester D&E: a case series","volume":"88","author":"Maurer","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.05.006_bib62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.contraception.2016.02.032","article-title":"A\u00a0randomized controlled trial evaluating same-day mifepristone and misoprostol compared to misoprostol alone for cervical preparation prior to second-trimester surgical abortion","volume":"94","author":"Casey","year":"2016","journal-title":"Contraception"},{"issue":"13","key":"10.1016\/j.bpobgyn.2019.05.006_bib63","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/1471-0528.14900","article-title":"Preoperative effects of mifepristone for dilation and evacuation after 19 weeks of gestation: a randomised controlled trial","volume":"124","author":"Shaw","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2019.05.006_bib64","series-title":"International planned parenthood federation","year":"2019"},{"issue":"8","key":"10.1016\/j.bpobgyn.2019.05.006_bib65","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMsb1612526","article-title":"Sixteen years of overregulation: time to unburden Mifeprex","volume":"376","author":"Raymond","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.05.006_bib66","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/AOG.0000000000001671","article-title":"Gynecology. Intra-fetal compared with intra-amniotic digoxin before dilation and evacuation","volume":"128","author":"White","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2019.05.006_bib67","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.contraception.2010.01.018","article-title":"Induction of fetal demise before abortion","volume":"81","author":"Diedrich","year":"2010","journal-title":"Contraception"},{"issue":"S3","key":"10.1016\/j.bpobgyn.2019.05.006_bib68","first-page":"158","article-title":"Intrafetal injection of lidocaine to induce fetal demise","volume":"143","author":"Reeves","year":"2018","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693419300495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693419300495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:11:06Z","timestamp":1761498666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693419300495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":68,"alternative-id":["S1521693419300495"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.05.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and potential methods for second trimester abortion","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}